These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23353864)

  • 1. Appetite suppressants in pregnancy.
    Manakova E; Kralova T; Hubičková Heringová L
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():179-82. PubMed ID: 23353864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
    Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
    Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
    Jick H; Vasilakis C; Weinrauch LA; Meier CR; Jick SS; Derby LE
    N Engl J Med; 1998 Sep; 339(11):719-24. PubMed ID: 9731087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.
    De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
    Drug Saf; 2006; 29(3):255-9. PubMed ID: 16524324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity.
    Arterburn D
    Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term health benefits of appetite suppressants remain unproven.
    Paumgartten FJ
    Rev Saude Publica; 2011 Dec; 45(6):1192-6. PubMed ID: 22232806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction induced by appetite suppressants in Malaysia.
    Azarisman SM; Magdi YA; Noorfaizan S; Oteh M
    N Engl J Med; 2007 Nov; 357(18):1873-4. PubMed ID: 17978302
    [No Abstract]   [Full Text] [Related]  

  • 9. Topiramate + phentermine. An excessively dangerous appetite-suppressant combination.
    Prescrire Int; 2013 Mar; 22(136):61-4. PubMed ID: 23593686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
    James WP; Caterson ID; Coutinho W; Finer N; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Shepherd GM; Rode RA; Renz CL;
    N Engl J Med; 2010 Sep; 363(10):905-17. PubMed ID: 20818901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A
    Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetite suppressants and valvular heart disease.
    Devereux RB
    N Engl J Med; 1998 Sep; 339(11):765-6. PubMed ID: 9731094
    [No Abstract]   [Full Text] [Related]  

  • 16. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 17. Sibutramine for obesity.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies confirm link between fen-phen and heart-valve disease.
    Harv Heart Lett; 1998 Dec; 9(4):4-6. PubMed ID: 9925979
    [No Abstract]   [Full Text] [Related]  

  • 19. Sibutramine: new preparation. Slight weight loss; but also a slight rise in blood pressure ..
    Prescrire Int; 2001 Oct; 10(55):140-5. PubMed ID: 11824428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. After fen-phen.
    Cowley G; Springen K
    Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.